University of Parma   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Parma Italy (1332)

Organization Overview

First Clinical Trial
1994
NCT00502034
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Azienda Ospedaliera-Universitaria di Parma | Azienda Ospedaliero-Universitaria di Parma | Azienda Ospedaliero-Universitaria di Parma, Parma, Italy | Azienda Unità Sanitaria Locale Reggio Emilia | Department of Food and Drugs | Dept. of Anesthesiology and Critical Care Medicine, University of Parma, Italy | Hospital Clinica Nova | Hospital Clínica Nova | II Unit of Anesthesia, Critical Care and Pain Medicine, University Hospital of Parma, Italy | Medical Oncology Unit - University Hospital of Parma | Parma University | Section of Anesthesiology and Critical Care, Dept. of Anesthesiology, University of Parma, Italy | Section of Anesthesiology and Critical Care, Dept. of Surgical Sciences, University of Parma | Universita degli Studi di Parma | Universitaria di Parma | University Hospital of Parma: Department of Biomedical, Biotechnological and Translational Sciences, Pathological Anatomy and Histology Unit | University Hospital of Parma:Laboratory of Viral Immunopathology, Unit of Infectious Diseases and Hepatology | University Hospital of Parma:Statistica medica ed epidemiologia clinica-UO Ricerca e Innovazione | University Hospitals Parma Medical Center | University of Parma | UO II Anestesia e Rianimazione, Azienda Ospedaliero-Universitaria di Parma | UO II Anestesia, Rianimazione e Terapia Antalgica, AOU Parma | UO II Anestesia, Rianimazione e Terapia Antalgica, Azienda Ospedaliero-Universitaria di Parma | UO Nefrologia, Azienda Ospedaliero-Universitaria di Parma